Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)

Launched by LILLE CATHOLIC UNIVERSITY · Oct 7, 2024

Keywords

ClinConnect Summary

The IMUSEP trial is studying how well a special device called the Trigno® Avanti Sensor can help identify and understand walking difficulties in people with multiple sclerosis (MS). Researchers want to see if this device can detect early problems with balance and coordination in MS patients compared to people without the condition. This information could be important for improving care and treatment for those with MS.

To participate in the trial, you need to be between 18 and 65 years old and speak French. You should also have a mild to moderate level of disability due to MS, as measured by a specific scale. Participants will undergo tests involving walking and balance activities while using the sensor. It's important to note that certain health conditions or recent medical treatments may exclude you from joining the study, such as having a recent MS crisis or certain neurological issues. If you meet the criteria, this could be a valuable opportunity to contribute to research that aims to enhance the understanding of MS-related movement challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria for patient:
• • Age 18 to 65 (inclusive)
• • Expanded Disability Status Scale (EDSS) ≤ 4
• • Proficient in French
• • Agreeing to participate in the study and having signed the informed consent form
• • Affiliated with a social security scheme
• Inclusion Criteria for Volunteers:
• • Age 18 to 65 (inclusive)
• • Proficient in French
• • Agreeing to participate in the study and having signed the informed consent form
• • Affiliated with a social security plan
• Exclusion Criteria for patient:
• • MS crisis within the last 6 weeks
• • Botulinum toxin injection in the last 3 months
• • Neurological pathology other than MS
• • Disabling musculoskeletal pathology
• • Unstable cardiac and respiratory pathology
• • Pregnant women
• • Patients with comprehension or cognitive disorders
• • Recent change in background treatment (\< 3 months)
• • Patients under guardianship or curatorship
• • Presence of implanted electronic devices of any kind, including pacemakers or similar assistive devices, electronic infusion pumps and implanted pacemakers
• • Allergy to silver
• Exclusion Criteria for Volunteers:
• • Neurological pathology
• • Rheumatological pathology
• • Antecedent of sprains (\< 3 months), fractures (\< 1 year) in the lower limbs
• • Pregnant women
• • Person under guardianship or trusteeship
• • Presence of implanted electronic devices of any kind, including pacemakers or similar assistive devices electronic infusion pumps and implanted pacemakers
• • Allergy to silver